351.

Weeding E, Fava A, Buyon J, Belmont H, Izmirly P, Clancy R, Monroy-Trujillo J, Fine D, Apruzzese W, Mischak H, Petri M.

Urine Proteomic Classifiers Predict Renal Histological Activity and Chronicity Indices and May Predict Treatment Response in Lupus Nephritis.

Arthritis Rheumatol. 2020; 72 (suppl 10).

PMID: 33166082

doi: 10.1002/art.41538

 

 

350.

Rudnicki M, Siwy J, Wendt R, Lipphardt M, Koziolek MJ, Maixnerova D, Peters B, Kerschbaum J, Leierer J, Neprasova M, Banasik M, Sanz AB, Perez-Gomez MV, Ortiz A, Stegmayr B, Tesar V, Mischak H, Beige J, Reich HN

Urine proteomics for prediction of disease progression in patients with IgA nephropathy.

 

349.

Fédou C, Breuil B, Golovko I, Decramer S, Magalhães P, Muller F, Dreux S, Zürbig P, Klein J, Schanstra JP, Buffin-Meyer B.

Comparison of the amniotic fluid and fetal urine peptidome for biomarker discovery in renal developmental disease.

 

348.

347.

Mokou M, Lygirou V, Angelioudaki I, Paschalidis N, Stroggilos R, Frantzi M, Latosinska A, Bamias A, Hoffmann MJ, Mischak H, Vlahou A.

A Novel Pipeline for Drug Repurposing for Bladder Cancer Based on Patients' Omics Signatures.

 

346.

 

345.

Wendt R, Kalbitz S, Lübbert C, Kellner N, Macholz M, Schroth S, Ermisch J, Latosisnka A, Arnold B, Mischak H, Beige J, Metzger J.

Urinary Proteomics Associates with COVID-19 Severity: Pilot Proof-of-Principle Data and Design of a Multicentric Diagnostic Study.

 

344.

Klein J, Caubet C, Camus M, Makridakis M, Denis C, Gilet M, Feuillet G, Rascalou S, Neau E, Garrigues L, Thillaye du Boullay O, Mischak H, Monsarrat B, Burlet-Schiltz O, Vlahou A, Saulnier-Blache JS, Bascands JL, Schanstra JP.

Connectivity mapping of glomerular proteins identifies dimethylaminoparthenolide as a new inhibitor of diabetic kidney disease.

 

343.

Wendt R, He T, Latosinska A, Siwy J, Mischak H, Beige J.

Proteomic characterization of obesity-related nephropathy.

 

342.

Frantzi M, Hupe MC, Merseburger AS, Schanstra JP, Mischak H, Latosinska A.

Omics Derived Biomarkers and Novel Drug Targets for Improved Intervention in Advanced Prostate Cancer.

 

341.

Latosinska A, Davalieva K, Makridakis M, Mullen W, Schanstra JP, Vlahou A, Mischak H, Frantzi M.

Molecular Changes in Tissue Proteome during Prostate Cancer Development: Proof-of-Principle Investigation.

 

340.

Maria Frantzi , Enrique Gomez-Gomez & Harald Mischak

Non-invasive biomarkers to guide intervention: towards personalized patient management in prostate cancer

Received 08 May 2020, Accepted 13 Jul 2020, Accepted author version posted online: 03 Aug 2020

View Abstract:   Request Reprint

 

339.

G. N. Baltas , F. A. Prieto, M. Frantzi, C. R. Garcia-Alonso, P. Rodriguez

Data Driven Modelling of Coronavirus Spread in Spain

CMC-Computers, Materials & Continua, Vol.64, No.3, pp. 1343-1357, 2020,

DOI:10.32604/cmc.2020.011243

View Abstract:   Request Reprint

 

338.

Wendt R, He T, Latosinska A, Siwy J, Mischak H, Beige J.

Proteomic characterization of obesity-related nephropathy.

Clin Kidney J. 2020 Apr 15;13(4):684-692. doi: 10.1093/ckj/sfaa016. eCollection 2020 Aug.

PMID: 32905225

View Abstract:   Request Reprint

 

337.

Klein J, Buffin-Meyer B, Boizard F, Moussaoui N, Lescat O, Breuil B, Fedou C, Feuillet G, Casemayou A, Neau E, Hindryckx A, Decatte L, Levtchenko E, Raaijmakers A, Vayssière C, Goua V, Lucas C, Perrotin F, Cloarec S, Benachi A, Manca-Pellissier MC, Delmas HL, Bessenay L, Le Vaillant C, Allain-Launay E, Gondry J, Boudailliez B, Simon E, Prieur F, Lavocat MP, Saliou AH, De Parscau L, Bidat L, Noel C, Floch C, Bourdat-Michel G, Favre R, Weingertner AS, Oury JF, Baudouin V, Bory JP, Pietrement C, Fiorenza M, Massardier J, Kessler S, Lounis N, Auriol FC, Marcorelles P, Collardeau-Frachon S, Zürbig P, Mischak H, Magalhães P, Batut J, Blader P, Saulnier Blache JS, Bascands JL, Schaefer F, Decramer S, Schanstra JP; BIOMAN consortium.

Amniotic fluid peptides predict postnatal kidney survival in developmental kidney disease.

Kidney Int. 2020 Aug 1:S0085-2538(20)30894-2. doi: 10.1016/j.kint.2020.06.043. Online ahead of print.

PMID: 32750455

View Abstract:   Request Reprint

 

336.

Campbell RT, Jasilek A, Mischak H, Nkuipou-Kenfack E, Latosinska A, Welsh PI, Jackson CE, Cannon J, McConnachie A, Delles C, McMurray JJV.

The novel urinary proteomic classifier HF1 has similar diagnostic and prognostic utility to BNP in heart failure.

ESC Heart Fail. 2020 Aug;7(4):1595-1604. doi: 10.1002/ehf2.12708. Epub 2020 May 8.

PMID: 32383555

View Abstract:   Request Reprint

 

335.

Latosinska A, Siwy J, Faguer S, Beige J, Mischak H, Schanstra JP.

Value of Urine Peptides in Assessing Kidney and Cardiovascular Disease.

Proteomics Clin Appl. 2020 Jul 25:e2000027. doi: 10.1002/prca.202000027. Online ahead of print.

PMID: 32710812

View Abstract:   Request Reprint

 

334.

He T, Pejchinovski M, Mullen W, Beige J, Mischak H, Jankowski V.

Peptides in Blood, Urine and Dialysate: Towards Unravelling Renal Peptide Handling.

Proteomics Clin Appl. 2020 Jul 3:e2000029. doi: 10.1002/prca.202000029. Online ahead of print.

PMID: 32618437

View Abstract:   Request Reprint

 

333.

He T, Siwy J, Metzger J, Mullen W, Mischak H, Schanstra JP, Zürbig P, Jankowski V.

Associations of urinary polymeric immunoglobulin receptor peptides in the context of cardio-renal syndrome.

Sci Rep. 2020 May 19;10(1):8291. doi: 10.1038/s41598-020-65154-2.

PMID: 32427855

View Abstract:   Request Reprint

 

332.

Mischak H.

Datasharing: Obsolete? Impossible in times of GDPR ? Or mandatory in science?!

Eur J Clin Invest. 2020 Apr 19:e13244. doi: 10.1111/eci.13244. Online ahead of print.

PMID: 32306378

View Abstract:   Request Reprint

 

331.

Pejchinovski M, Mischak H.

Re-analysis of "Peptidomic analysis of cartilage and subchondral bone in OA patients".

Eur J Clin Invest. 2020 Apr 18:e13240. doi: 10.1111/eci.13240. Online ahead of print.

PMID: 32306374

View Abstract:   Request Reprint

 

330.

Weissinger EM, Basílio-Queirós D, Metzger J, Bieling LM, Ganser A.

Proteomics for hematopoietic stem cell transplantation.

Expert Rev Proteomics. 2020 Mar;17(3):201-206. doi: 10.1080/14789450.2020.1748501. Epub 2020 Apr 4.

PMID: 32228239

View Abstract:   Request Reprint

 

329.

Makridakis M, Kontostathi G, Petra E, Stroggilos R, Lygirou V, Filip S, Duranton F, Mischak H, Argiles A, Zoidakis J, Vlahou A.

Multiplexed MRM-based protein quantification of putative prognostic biomarkers for chronic kidney disease progression in plasma.

Sci Rep. 2020 Mar 16;10(1):4815. doi: 10.1038/s41598-020-61496-z.

PMID: 32179759

View Abstract:   Request Reprint

 

328.

Buffin-Meyer B, Tkaczyk M, Stańczyk M, Breuil B, Siwy J, Szaflik K, Talar T, Wojtera J, Krzeszowski W, Decramer S, Klein J, Schanstra JP.

A single-center study to evaluate the efficacy of a fetal urine peptide signature predicting postnatal renal outcome in fetuses with posterior urethral valves.

Pediatr Nephrol. 2020 Mar;35(3):469-475. doi: 10.1007/s00467-019-04390-9. Epub 2019 Nov 7.

PMID: 31701236

View Abstract:   Request Reprint

 

327.

Tofte N, Lindhardt M, Adamova K, Bakker SJL, Beige J, Beulens JWJ, Birkenfeld AL, Currie G, Delles C, Dimos I, Francová L, Frimodt-Møller M, Girman P, Göke R, Havrdova T, Heerspink HJL, Kooy A, Laverman GD, Mischak H, Navis G, Nijpels G, Noutsou M, Ortiz A, Parvanova A, Persson F, Petrie JR, Ruggenenti PL, Rutters F, Rychlík I, Siwy J, Spasovski G, Speeckaert M, Trillini M, Zürbig P, von der Leyen H, Rossing P;

Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial.

PRIORITY investigators. Lancet Diabetes Endocrinol. 2020 Apr;8(4):301-312. doi: 10.1016/S2213-8587(20)30026-7. Epub 2020 Mar 2.

PMID: 32135136

View Abstract:   Request Reprint

 

326.

Nkuipou-Kenfack E, Latosinska A, Yang WY, Fournier MC, Blet A, Mujaj B, Thijs L, Feliot E, Gayat E, Mischak H, Staessen JA, Mebazaa A, Zhang ZY

A novel urinary biomarker predicts 1-year mortality after discharge from intensive care.

French and European Outcome Registry in Intensive Care Unit Investigators. Crit Care. 2020 Jan 9;24(1):10. doi: 10.1186/s13054-019-2686-0.

PMID: 31918764

View Abstract:   Request Reprint

Voigtländer T, Metzger J, Husi H, Kirstein MM, Pejchinovski M, Latosinska A, Frantzi M, Mullen W, Book T, Mischak H, Manns MP.

 

325.

Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma.

J Biomed Sci. 2020 Jan 3;27(1):13. doi: 10.1186/s12929-019-0599-5.

PMID: 31900160

View Abstract:   Request Reprint

 

324.

Rosa Maria Bruno, Harald Mischak, Alexandre Persu

Multi-omics applied to fibromuscular dysplasia: first steps on a new research avenue

Cardiovasc Res . 2020 Jan 1;116(1):4-5. doi: 10.1093/cvr/cvz307.

PMID:: 31711122

View Abstract:   Request Reprint

 

323.

Siwy J, Ahonen L, Magalhães P, Frantzi M, Rossing P.

Metabolomic and Proteomic Techniques for Establishing Biomarkers and Improving Our Understanding of Pathophysiology in Diabetic Nephropathy.

Methods Mol Biol. 2020;2067:287-306. doi: 10.1007/978-1-4939-9841-8_18.

PMID: 31701458

View Abstract:   Request Reprint

 

322.

Stroggilos R, Mokou M, Latosinska A, Makridakis M, Lygirou V, Mavrogeorgis E, Drekolias D, Frantzi M, Mullen W, Fragkoulis C, Stasinopoulos K, Papadopoulos G, Stathouros G, Lazaris AC, Makrythanasis P, Ntoumas K, Mischak H, Zoidakis J, Vlahou A.

Proteome-based classification of Nonmuscle Invasive Bladder Cancer.

Int J Cancer. 2020 Jan 1;146(1):281-294. doi: 10.1002/ijc.32556. Epub 2019 Jul 26.

PMID: 31286493

View Abstract:   Request Reprint